Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
vitae. A motivation letter of a maximum of two A4 pages. A concise research proposal of max 500 on how you would frame the project. If available, a copy of an article, book chapter or other academic text
-
set of application files (in English): EGSL application form including a research proposal (max 2000 words), merged in 1 document, motivation letter (max 2 pages), CV, copy Master’s diploma and
-
involving millions of individuals. Emerging methods using population-scale microdata now allow us to construct large-scale models of social opportunity structures, offering a promising new avenue for
-
with other bioprinting techniques (including volumetric bioprinting and melt electrowriting). You will use this versatile set-up to produce complex 3D tissues as advanced in vitro models for cardiac and
-
to characterize the molecular properties of catalysts together with statistical methods to derive predictive models for selective catalysis. In a data-driven approach, an initial set of reactions is analyzed and
-
through our Terms of Employment Options Model. In this way, we encourage our employees to continue to invest in their growth. For more information, please visit Working at Utrecht University external link
-
early steps in lung tumor development. You will use cutting-edge techniques including lung organoid models, single-cell transcriptomics and epigenomics, and CRISPR-based genetic perturbation. Key
-
/ Information and application Send a motivation letter, a CV, including the email addresses of two references, a grade transcript and a copy of your Master’s thesis and and preferably a list of publications
-
. You will work here The project is a part of Open Technology grant for our proposal COre-based PYrrolizydine alkaloid synthesis for Contaminant Annotation and Tracking ( COPY-CAT ). The research is
-
for our proposal COre-based PYrrolizydine alkaloid synthesis for Contaminant Annotation and Tracking (COPY-CAT ). The research is embedded within the group of Dr. Laura Righetti and Dr. Gert Salentijn